Name: 43% of Covid patients in India who died had no comorbidities: Govt analysis
Brand: theprint.in
SKU: theprint-in-25
Availability: OnlineOnly

critic

43% of Covid patients in India who died had no comorbidities: Govt analysis

preview

Sign inWelcome! Log into your accountPassword recoveryRecover your passwordA password will be e-mailed to you.Text Size:A-A+New Delhi: Over five months after the first Covid-19 case was reported in India, a government analysis of deaths reported until 2 July shows that just a little less than half of them have happened in young people — those below 60 years of age. In 43 per cent of the deaths, there were no known comorbidities.This flies in the face of repeated claims by the Narendra Modi government that most of the Covid patients who died had comorbidities.The analysis has been done by the Integrated Disease Surveillance Programme, which functions under the Ministry of Health and Family Welfare (MoHFW), and is key to tracking all infectious diseases in the country.While all the 17,834 deaths recorded until July were analysed, comorbidity and age group data was available only for 15,962 deaths as three states — Delhi, Uttar Pradesh and Maharashtra — have not been sharing data on comorbidities regularly, the IDSP said.The last time official data about the mortality profiles was officially given out before this was on 21 May, at which time deaths in people with comorbidities stood at 73 per cent. The total cases at the point was at 1,12,359 lakh, and 3,435 deaths.On Friday, the total number of cases in the country stood at 6,25,844, including 18,213 deaths.According to the IDSP analysis, the age-wise breakup of deaths shows that 0.54 per cent deaths were in children aged less than 14 years, 2.64 per cent in people aged between 15-29, 10.82 per cent in people aged 30-44 years, 32.79 per cent in the 45-59 age group, 39.02 per cent in the 60-74 age group and 12.88 per cent in people aged over 75 years.The break-up shows that while over half of the deaths are occurring among senior citizens — a group that has been repeatedly asked to stay at home even after the unlocking process began — there is a significant proportion of mortality in the 45-59 age group.Almost one in every three Covid deaths in India is happening in this group — often regarded as the most productive years of an average person’s life.Also read:&nbsp;That Covid patients with existing health conditions (comorbidities) are more vulnerable than others has always been known. In the initial days of the outbreak, every time a death happened, the Government of India statement usually attributed it to a long list of comorbidities.However, the latest IDSP analysis shows that comorbidities were found in 57 per cent Covid deceased until 2 July. For the others, it was this disease alone that was responsible for the death.Among the comorbidities that make Covid patients high-risk are diabetes, hypertension, obesity, heart diseases, cancer and respiratory diseases.In May this year, a in the European Respiratory Journal that had looked at 1,590 Covid patients in China, had concluded: “Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.”An analysis of New York deaths by statistics website Worldometer links 89 per cent deaths in that city to comorbidities.The case fatality ratio in India on 2 July stood at 3 per cent. Case fatality ratio is the percentage of deaths from among all reported cases, as opposed to infection fatality ratio that takes into account undiagnosed cases at the population level too.The analysis also shows that 68 per cent of all deaths in India were among male.This is in line with global trends, although some Indian analyses have claimed that the case fatality ratio in Indian women is higher than the international experience. In a in April, researchers from China reported in the Journal of Public Health that the risk of death in a male Covid patient is 2.4 times that of a woman.This report has been updated to correct typographical errors in the graphics.Also read:&nbsp;&nbsp;Support Our JournalismIndia needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.Sustaining this needs support from wonderful readers like you.Whether you live in India or overseas, you can take a paid subscription by clicking .The article seems to be targetted against Narendra Modi/BJP Govt. rather than pointing out facts – hate journalism – no use, really.You guys really need to check your graphs before you post them. Labelling errors are just lazy.These errors are seen often on “cut the clutter” videos as well.Your infographics guy is a mathematical genius. He has reversed the concept of percentage and age groups. It’s enlightening to know that 43% is more than 57% (pie chart) and the number 15 comes after 30 and 44 (bar chart).Graph is incorrect how is 57% less than 43%.🤣🤣🤣I think rahul baba didn’t train you well. Or may be my maths is not strong enough.And can you please share where you got this information. That might be little helpful. I will share this and help people to know thisComments are closed.Substance of Print, Reach of DigitalContact us:Copyright © 2022 Printline Media Pvt. Ltd. All rights reserved.&nbsp;

Sign inWelcome! Log into your accountPassword recoveryRecover your passwordA password will be e-mailed to you.Text Size:A-A+New Delhi: Over five months after the first Covid-19 case was reported in India, a government analysis of deaths reported until 2 July shows that just a little less than half of them have happened in young people — those below 60 years of age. In 43 per cent of the deaths, there were no known comorbidities.This flies in the face of repeated claims by the Narendra Modi government that most of the Covid patients who died had comorbidities.The analysis has been done by...

43% of Covid patients in India who died had no comorbidities: Govt analysis

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS